Nanobiotix S.A. American Depositary Shares (NBTX) Stock Price

NBTXStock

$21.30−0.52%52W

Market Cap$1.08B

P/E—

PEG Ratio—

Div yield—

Beta-0.23

NBTX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-43.29%

Price vs S&P 500 (4W)-34.21%

VGM Score41.06

Book Value / Share (Quarterly)$0.06

P/TBV (Annual)9.50x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.79

Price vs S&P 500 (YTD)-12.50%

Net Profit Margin (TTM)-80.84%

EPS (TTM)$-0.56

10-Day Avg Trading Volume0.17M

EPS Excl Extra (TTM)$-0.56

Revenue Growth (5Y)258.58%

EPS (Annual)$-0.56

ROI (Annual)-67.39%

Gross Margin (Annual)100.00%

Net Profit Margin (5Y Avg)-122461.58%

Cash / Share (Quarterly)$1.22

Revenue Growth QoQ (YoY)304.48%

ROA (Last FY)-35.36%

Revenue Growth TTM (YoY)-80.24%

EBITD / Share (TTM)$-0.23

ROE (5Y Avg)-124.29%

Operating Margin (TTM)-38.11%

Cash Flow / Share (Annual)$-0.79

P/B Ratio559.71x

P/B Ratio (Quarterly)65.40x

Net Income / Employee (Annual)$-277,260

EV / Revenue (TTM)35.27x

Net Interest Coverage (TTM)-0.89x

ROA (TTM)-42.44%

EPS Incl Extra (Annual)$-0.56

Current Ratio (Annual)1.09x

Quick Ratio (Quarterly)1.05x

3-Month Avg Trading Volume0.14M

52-Week Price Return-0.52%

Revenue / Employee (TTM)$343,039

Tangible BV / Share (Quarterly)$0.06

P/S Ratio (Annual)33.84x

Asset Turnover (Annual)0.44x

52-Week High$53.50

Operating Margin (5Y Avg)-133512.98%

EPS Excl Extra (Annual)$-0.56

CapEx CAGR (5Y)38.54%

Tangible BV CAGR (5Y)11.42%

26-Week Price Return-33.38%

Quick Ratio (Annual)1.05x

13-Week Price Return-38.87%

Total Debt / Equity (Annual)1.60x

Current Ratio (Quarterly)1.09x

Enterprise Value$1.17B

Revenue / Share Growth (5Y)211.90%

Asset Turnover (TTM)0.53x

Book Value / Share Growth (5Y)-6.95%

Revenue / Employee (Annual)$343,039

Pretax Margin (Annual)-80.83%

Cash / Share (Annual)$1.22

3-Month Return Std Dev67.21%

Net Income / Employee (TTM)$-277,260

ROE (Last FY)-175.45%

Net Interest Coverage (Annual)-0.89x

EPS Basic Excl Extra (Annual)$-0.56

Receivables Turnover (TTM)11.60x

Total Debt / Equity (Quarterly)23.58x

EPS Incl Extra (TTM)$-0.56

Receivables Turnover (Annual)11.60x

ROI (TTM)-75.47%

P/S Ratio (TTM)33.84x

Pretax Margin (5Y Avg)-122447.02%

Revenue / Share (Annual)$0.70

Tangible BV / Share (Annual)$0.86

Price vs S&P 500 (52W)-16.05%

Year-to-Date Return-1.95%

5-Day Price Return-8.69%

EPS Normalized (Annual)$-0.56

ROA (5Y Avg)-64.07%

Net Profit Margin (Annual)-80.84%

Month-to-Date Return-30.72%

Cash Flow / Share (TTM)$-1.84

EBITD / Share (Annual)$-0.23

Operating Margin (Annual)-38.11%

LT Debt / Equity (Annual)1.13x

ROI (5Y Avg)-68.91%

LT Debt / Equity (Quarterly)16.13x

EPS Basic Excl Extra (TTM)$-0.56

P/TBV (Quarterly)65.43x

P/B Ratio (Annual)9.50x

Pretax Margin (TTM)-80.83%

Book Value / Share (Annual)$0.86

Price vs S&P 500 (13W)-41.56%

Beta-0.23x

Revenue / Share (TTM)$0.69

ROE (TTM)-300.48%

52-Week Low$14.70

vGradeF

gGradeB

mGradeC

vgmGradeC

NBTX Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.17

Industry Peers — Pharmaceuticals(574)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
NBTXNanobiotix S.A. American Depositary Shares	F	B	C	33.8x	-80.2%	—	—	$21.30
LLYEli Lilly & Co.	D	B	A	14.9x	49.6%	83.4%	27.6%	$1257.03
JNJJohnson & Johnson	D	C	B	6.2x	7.8%	67.7%	14.9%	$255.56
ABBVABBVIE INC.	D	C	A	7.8x	10.4%	72.8%	-2.9%	$285.42
MRKMerck & Co., Inc.	D	C	A	5.4x	4.6%	77.3%	21.2%	$145.95
NVSNovartis AG	C	C	B	4.9x	3.3%	75.0%	15.3%	$150.62
AZNAstraZeneca PLC	C	B	B	4.3x	8.6%	81.3%	21.9%	$165.41
ABTAbbott Laboratories	C	C	B	3.9x	8.1%	56.8%	8.2%	$104.89
NVONovo-Nordisk A/S	B	C	C	3.5x	5.6%	80.7%	20.7%	$38.83
PFEPfizer Inc.	C	D	A	2.6x	-0.2%	74.7%	-3.5%	$29.58
VRTXVertex Pharmaceuticals Inc	D	C	B	10.1x	10.2%	86.0%	8.3%	$499.74
BMYBristol-Myers Squibb Co.	B	B	B	2.5x	3.1%	71.7%	—	$59.75
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	C	C	B	2.3x	5.0%	73.6%	-0.5%	$49.51
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	D	B	1.8x	13.4%	72.8%	-8.2%	$40.61
REGNRegeneron Pharmaceuticals Inc	C	C	A	5.2x	9.3%	86.0%	6.3%	$790.74
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	A	2.1x	3.1%	65.5%	-12.6%	$19.67
TEVATeva Pharmaceutical Industries Limited	D	C	A	2.8x	4.1%	52.9%	—	$41.50
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	6.3x	31.1%	88.5%	—	$369.06
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	A	13.8x	10.0%	—	-12.1%	$60.96
ZTSZOETIS INC.	C	C	B	3.5x	1.4%	71.6%	12.0%	$79.38
ALNYAlnylam Pharmaceuticals, Inc.	D	A	C	6.5x	95.1%	79.7%	—	$231.83
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	3215.5x	-67.6%	81.2%	—	$33.53
UTHRUnited Therapeutics Corp	C	C	B	7.2x	2.5%	86.1%	19.3%	$533.12
GMABGenmab A/S ADS	D	C	A	5.5x	22.3%	93.0%	6.8%	$37.00
VTRSViatris Inc. Common Stock	B	C	A	1.5x	4.4%	40.3%	—	$18.66
INSMInsmed, Inc.	F	A	C	18.5x	185.8%	83.5%	—	$96.27
ASNDAscendis Pharma A/S Ordinary Share	D	A	B	11.9x	113.3%	91.3%	—	$225.25
JAZZJazz Pharmaceuticals, Inc.	B	C	B	3.0x	12.6%	88.4%	-1.4%	$210.23
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	18.2x	202.4%	94.4%	—	$66.39
CORTCorcept Therapeutics Inc.	F	C	A	14.3x	16.0%	98.3%	-0.5%	$110.16
ELANElanco Animal Health Incorporated Common Stock	D	B	B	2.3x	11.9%	55.4%	29.9%	$23.55
SMMTSummit Therapeutics Inc. Common Stock	F	—	C	12187.5x	—	—	—	$14.63
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	C	B	3.1x	-0.9%	61.4%	16.5%	$13.07
BMRNBioMarin Pharmaceuticals Inc	C	C	B	3.1x	11.2%	79.6%	-17.0%	$54.68
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	8.1x	149.0%	91.5%	—	$449.74
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	213.8x	2928.4%	—	—	$84.95
CYTKCytokinetics Inc.	F	D	B	127.3x	-21.1%	—	—	$61.95
PTGXProtagonist Therapeutics, Inc	F	B	B	29.5x	34.8%	—	—	$128.75
TGTXTG Therapeutics, Inc.	D	B	B	10.3x	76.1%	82.4%	—	$53.97
AXSMAxsome Therapeutics, Inc	D	B	C	10.6x	56.9%	93.2%	—	$157.14
ARWRArrowhead Research Corporation	D	A	C	11.8x	16.9%	—	—	$55.90
ABVXAbivax SA American Depositary Shares	—	—	C	—	—	—	—	$88.13
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	5995.2x	—	—	—	$79.90
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	8.2x	-7.5%	98.2%	—	$42.94
ALKSAlkermes Inc. plc	D	C	B	4.1x	10.8%	84.6%	—	$41.22
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	789.2x	—	—	—	$241.76
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	D	C	A	2.0x	9.3%	39.3%	-18.4%	$19.18
KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares	D	B	A	7.3x	58.9%	89.8%	—	$78.59
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	24.7x	53.5%	70.9%	—	$86.17
LGNDLigand Pharmaceuticals Inc.	D	B	B	20.3x	54.9%	95.4%	—	$295.54
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	—	—	—	—	$142.78

About Nanobiotix S.A. American Depositary Shares

Nanobiotix SA is a clinical-stage biotechnology company developing proprietary nanotechnology to enhance the effectiveness of cancer radiotherapy. Its NanoXray platform amplifies radiation effects within tumor cells without increasing exposure to surrounding healthy tissue. The company's lead candidate, NBTXR3, is being evaluated for cancer immunotherapy applications.